Homatropine

BRAND NAMES

• Isopto Homatropine

• Hycodan

• Homatropine hydrobromide eye drops (generic labeling in many regions)

MECHANISM OF ACTION

Homatropine is a competitive antagonist of muscarinic receptors (mainly M3) in the eye. It blocks acetylcholine action on the iris sphincter and ciliary muscles, leading to pupil dilation (mydriasis) and temporary loss of accommodation (cycloplegia).

PHARMACOKINETICS

Absorption

Homatropine is absorbed mainly through the cornea and conjunctiva when used as eye drops. A small amount may also enter systemic circulation via the nasolacrimal duct, but systemic effects are usually mild due to its limited absorption and lower potency.

Distribution

Homatropine has minimal systemic distribution because it is mainly used as eye drops. Most of the drug acts locally in ocular tissues, while only a small fraction (generally less than 10–20%) may be absorbed into systemic circulation through the nasolacrimal pathway.

Metabolism

Homatropine is minimally metabolized after topical ophthalmic use. The small fraction that is systemically absorbed undergoes hepatic metabolism (liver), primarily through enzymatic hydrolysis and breakdown into inactive metabolites.

Elimination

Homatropine is eliminated mainly through the kidneys after minimal systemic absorption. Most of the drug acts locally in the eye and is cleared via tear drainage, while the small absorbed portion is excreted in urine as inactive metabolites.

PHARMACODYNAMICS

Homatropine is a competitive muscarinic acetylcholine receptor antagonist that acts primarily on M3 receptors in the eye. By blocking parasympathetic stimulation, it relaxes the iris sphincter muscle causing mydriasis (pupil dilation) and the ciliary muscle causing cycloplegia (loss of accommodation). Its effects are reversible and shorter in duration compared to atropine, making it suitable for diagnostic ophthalmic use. It does not have significant systemic pharmacodynamic effects at normal topical doses.

ADMINISTRATION

Homatropine is mainly administered as ophthalmic eye drops, typically in concentrations such as 2% or 5% homatropine hydrobromide, used for pupil dilation and cycloplegia during eye examinations. It is applied directly into the conjunctival sac, where it acts locally on the eye. In some cases, it may be given as eye ointment, but topical ophthalmic use is the standard route of administration.

DOSAGE AND STRENGTH

Homatropine is commonly available as ophthalmic eye drops in strengths of 2% and 5% homatropine hydrobromide. In adults, it is usually instilled as 1–2 drops in the affected eye, repeated as needed for diagnostic mydriasis or cycloplegia under medical supervision. The exact dose and frequency depend on the clinical purpose and patient response.

DRUG INTERACTIONS

Homatropine may interact with other anticholinergic drugs (such as antihistamines, tricyclic antidepressants, and other atropine-like agents), leading to enhanced side effects like dry mouth, blurred vision, tachycardia, and urinary retention. It can also oppose the effects of cholinergic agents (like pilocarpine), reducing their therapeutic action. When used topically in the eye, systemic interactions are generally minimal but can still occur if significant absorption happens.

FOOD INTERACTIONS

Homatropine has no significant food interactions because it is used mainly as a topical eye drop with minimal systemic absorption. Food does not affect its absorption or effectiveness. However, if a small amount is systemically absorbed, it may add to anticholinergic side effects (like dry mouth or blurred vision), but this is not usually influenced by diet.

CONTRAINDICATIONS

Homatropine is contraindicated in patients with hypersensitivity to the drug or other anticholinergics, as it may cause allergic reactions. It should also be avoided in individuals with narrow-angle (angle-closure) glaucoma, since it can increase intraocular pressure by causing pupil dilation. Caution is required in patients with conditions like prostatic hypertrophy or urinary retention, where anticholinergic effects may worsen symptoms.

SIDE EFFECTS

• Blurred vision

• Photophobia (light sensitivity)

• Eye irritation or stinging

• Increased intraocular pressure (rare)

• Dry mouth (rare, systemic)

• Tachycardia (rare, systemic)

• Urinary retention (rare, systemic)

OVER DOSE

• Severe anticholinergic effects (dry mouth, flushed skin, fever)

• Marked tachycardia

• Confusion or agitation

• Blurred vision and extreme photophobia

• Urinary retention

TOXICITY

Homatropine toxicity is due to excessive anticholinergic effects, leading to symptoms such as dry mouth, flushed skin, fever, tachycardia, blurred vision, and urinary retention. In severe cases, especially in children, it may cause confusion, agitation, hallucinations, and delirium. Treatment is mainly supportive with medical care.